SCHEMBL2831398

SCHEMBL2831398

COc1cc(OC)cc(C(=O)C=CN2CCC(N3CCCC3)CC2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
USP2 O75604 2/20 0.50
MAPT P10636 2/20 0.50
NPC1 O15118 1/20 0.50
LMNA P02545 1/20 0.50
MAPK1 P28482 1/20 0.50
PKM P14618 1/20 0.49
KDM4E B2RXH2 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
ALOX12 P18054 1/20 0.47
ABCG2 Q9UNQ0 1/20 0.45
KDM2B Q8NHM5 4/20 0.41
HRH3 Q9Y5N1 2/20 0.41
L3MBTL3 Q96JM7 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM1 P11229 1/20 0.41
CHRM3 P20309 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4384539 0.90 PKM (0.58) ALDH1A1USP2MAPTNPC1LMNA
SCHEMBL4380675 0.89 PKM (0.60) ALDH1A1USP2MAPTNPC1LMNA
SCHEMBL2829775 0.87 ALDH1A1 (0.54) ALDH1A1USP2MAPTNPC1LMNA
SCHEMBL2829559 0.80 KDM2B (0.55) ALDH1A1USP2MAPTNPC1LMNA
SCHEMBL4379197 0.78 GAA (0.46) ALDH1A1USP2MAPTNPC1LMNA
SCHEMBL2829096 0.76 ALDH1A1 (0.51) ALDH1A1USP2MAPTNPC1LMNA
SCHEMBL2831229 0.75 ALDH1A1 (0.49) ALDH1A1USP2MAPTNPC1LMNA
SCHEMBL2830259 0.74 NPC1 (0.60) ALDH1A1USP2MAPTNPC1LMNA
SCHEMBL2831500 0.73 KDM4E (0.50) ALDH1A1USP2MAPTNPC1LMNA
SCHEMBL28966168 0.73 ALDH1A1 (0.76) ALDH1A1USP2MAPTNPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP claimed
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP disclosed